AneuRx Post Market Study in the Treatment of AAA

ClinicalTrials.gov ID: NCT00604552

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00604552. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:01 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

AneuRx Post Market Surveillance Registry

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The aorta is a large blood vessel that carries blood away from the heart to the organs in the rest of the body. An aneurysm is a weakening in the artery wall that will become a bulge in the aorta. If left untreated, this bulge may continue to grow larger and may rupture (break open) with fatal consequences. Abdominal aortic aneurysm (AAA) is a life-threatening lesion that has been treated in recent year via endovascular repair. The purpose of this study is to monitor the long term performance of the AneuRx Stent Graft Systems.

Study identification

NCT ID: NCT00604552
Recruitment status: Terminated
Study type: Interventional
Phase: Not applicable
Lead sponsor: Medtronic Cardiovascular; Industry
Enrollment: 349 participants

Conditions and interventions

Conditions

Abdominal Aneurysm

Interventions

AneuRx Stent Graft Device

Device

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 2003 (Type not available)
Primary completion: Feb 2008 (Actual)
Completion: Feb 2009 (Actual)
Last update posted: Oct 29, 2021

2003 – 2009

United States locations

U.S. sites: 8
U.S. states: 7
U.S. cities: 8

Facility	City	State	ZIP	Site status
Not listed	Tucson	Arizona	—	—
Not listed	Royal Oak	Michigan	—	—
Not listed	Morristown	New Jersey	—	—
Not listed	Asheville	North Carolina	—	—
Not listed	Chapel Hill	North Carolina	—	—
Not listed	Sioux Falls	South Dakota	—	—
Not listed	Memphis	Tennessee	—	—
Not listed	Norfolk	Virginia	—	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00604552, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 29, 2021 · Synced Nov 15, 2026